Advanced Drug Delivery Platforms
Advancing nasal, nose-to-brain and pulmonary drug delivery
Zeteo Biomedical applies its proprietary powder and liquid drug-delivery technology platforms to develop innovative drug-delivery devices and drug/device combination products with pharmaceutical, biotechnology and government partners. Our integrated technologies encompass delivery devices, unit-dose primary packaging, formulation and device optimization, analytical characterization, and scalable manufacturing solutions to support product development from early feasibility through clinical and commercial applications.
Routes of Drug Delivery
Our ZTech-P™ powder and ZTech-L™ liquid technology platforms support multiple routes and applications for drug delivery.
OrionMR™
Intranasal Liquid Delivery
Analytical Characterization
Capabilities include:
- Particle and Dispense Characterization via Laser Diffraction
- Plume Morphology via High-Speed Imaging
- In Vitro Respiratory Tract Deposition Studies
- Delivered Dose Uniformity and Consistency
- Emitted Dose / Mass Transfer
- Size Exclusion Chromatography
- Dissolution Studies
Product Development Support
Capabilities include:
- Formulation Development and Optimization
- Device and Primary Container Configuration
- Prototype Development and Supply
- Device and Dispense Characterization
- Fill Process Engineering and Optimization
- Preclinical and Clinical Supply
- Quality and Regulatory Documentation
Commercialization Support
Capabilities include:
- Technology Licensing
- Commercial Scale-Up and Technology Transfer
- Manufacturing Process Engineering and Optimization
- Automated Fill and Assembly Process Development
- Commercial Manufacturing Equipment and Tooling
- Equipment Installation, Qualification and Start-Up Support
Technology Platforms
Zeteo’s ZTech-P™ powder and ZTech-L™ liquid technology platforms integrate delivery devices, unit-dose primary packaging and scalable manufacturing approaches to support the development of drug-device combination products. The configurable platforms enable nasal, nose-to-brain, pulmonary and other non-invasive routes, with flexibility for a broad range of drugs, biologics and therapeutic applications.
Medical Countermeasures & Biosecurity
Zeteo Biomedical’s ZTech-P™ powder and ZTech-L™ liquid drug-delivery platforms support the development of medical countermeasures for infectious disease, chemical, biological, radiological and nuclear (CBRN) threats, and other public-health and national-security emergencies.
Our nasal, pulmonary and other non-invasive delivery technologies can be configured for vaccines, anti-infectives, antidotes and other therapeutic countermeasures where rapid, reliable administration is critical. Designed to support self-administration or caregiver use, Zeteo technologies offer flexible product configurations and scalable manufacturing approaches for deployment to individuals, warfighters, first responders and large populations under emergency conditions.
Applied Innovation
Zeteo integrates drug-delivery technology, formulation, primary packaging, aerosolization and manufacturing know-how to solve complex combination-product challenges. Our modular liquid and powder platforms can be configured for nasal, nose-to-brain, pulmonary and other routes of administration, enabling the formulation, dose, delivery characteristics and deposition profile to be engineered around the therapeutic objective, intended use and patient.
Innovation extends across the development pathway. Configurable animal and human delivery interfaces can support early preclinical studies and facilitate translation into clinical development, reducing the need to redesign the delivery approach as programs advance. Dose flexibility, multi-API and multi-formulation delivery, particle and deposition engineering, integrated unit-dose packaging, and scalable manufacturing provide multiple pathways to reduce development complexity while optimizing product performance, usability and differentiation.




